GSK Jurong is a mixed Global Supply Chain and R&D site. It features clinical and development small molecule manufacturing. Our Tres Cantos site, where medicines have been discovered and developed for over 25 years, is focused on discovering …

GSK today opens a £56 million state of the art manufacturing facility, creating 150 new jobs in the UK, in response to demand for GSK’s portfolio of respiratory medicines delivered by the innovative Ellipta inhaler.

Riverlabs is in the beautiful, thriving, riverside market town of Ware, home to GSK for over 50 years.

Jan 16, 2024 · GSK will lay out more than £200 million (about $253 million) through 2025 to bolster its U.K. supply network, including building new facilities and developing new assembly lines, a company...

The investments announced today comprise: New manufacturing facilities in Ware for the Relvar TM Ellipta TM inhaler – the latest generation of GSK’s inhaler devices for respiratory disease. The Ellipta device was developed at Ware and will now be produced at …

Apr 18, 2016 · GlaxoSmithKline (GSK) has expanded its respiratory medicines production capacity with the opening of a new £56m manufacturing facility in Ware, UK. More than £100m was invested in the new facility over the past five years, which has been built to cater to the demand of GSK’s respiratory medicines delivered by Ellipta inhaler.

Apr 20, 2016 · The U.K. drugmaker ($GSK) opened an $80.5 million (£56 million), 4,500-square-meter plant this week in Ware, U.K. The 48,437-square-foot expansion will allow the Ware site to nearly double...

Find company research, competitor information, contact details & financial data for GSK PLC of WARE. Get the latest business insights from Dun & Bradstreet.

Feb 12, 2025 · Phase 1 of the retrofit development works of a 90,255 sq ft former GSK laboratory at its 28-acre life science campus, Riverlabs, is now underway in Ware, Hertfordshire at the heart of the Golden Triangle.

Apr 21, 2016 · GSK has opened a £56 million manufacturing facility in Ware, creating 150 new UK jobs. The company created the state of the art facility in response to growing export demand for GSK’s portfolio of respiratory medicines delivered by the Ellipta inhaler.